IMRX EPS Estimates
Immuneering Corporation
$3.73
+$0.07(+1.91%)
28
Overall
40
Value
18
Tech
28
Quality
Market Cap
$241.32M
Volume
926.84K
52W Range
$3.38 - $8.48
Target Price
$17.50
IMRX EPS estimates: the consensus estimate for Immuneering Corporation's current fiscal year is -$1.09 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IMRX EPS Estimates
- EPS estimate, current quarter
- $-0.29
- EPS estimate, next quarter
- $-0.31
- EPS estimate, current year
- $-1.09
- EPS estimate, next year
- $-1.40
- EPS growth, 3-year
- +12.72%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.27 |
| 2024 | $-2.04 |
| 2023 | $-1.88 |
| 2022 | $-1.91 |
| 2021 | $-2.46 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMRX | $3.73 | +1.9% | 926.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |